Filter By:
Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.
Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.
Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended
Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro®, a therapeutic option
Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly
Aspen’s Stephen Saad and Sean Capazorio will take part in Investec’s CEO conference in London
Aspen’s donation of anaesthetics to Lebanese patients Johannesburg, South Africa – Aspen Global Incorporated, a subsidiary of Pharmacare Limited, Africa’s largest pharmaceutical company, has donated
Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some
Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical
Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company,
An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern Cape, South Africa,
Pretoria, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today participated in a high-level manufacturing seminar on manufacturing vaccines in Africa, hosted by South African President Cyril Ramaphosa and French President Emmanuel Macron.
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is celebrating its 10th year of participation in the
An Aspen Pharmacare initiative Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company headquartered in South Africa, has
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600
Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
